Implementation of COVID-19 Testing Strategies in Community Health Centers
NCT ID: NCT04802187
Last Updated: 2023-11-08
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
6 participants
INTERVENTIONAL
2020-12-01
2022-07-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Feasibility of Rapid COVID-19 Testing in Disadvantaged Populations
NCT04558307
Evaluating Public Health Interventions to Improve COVID-19 Testing Among Underserved Populations
NCT05270694
COVID-19 Testing in Underserved and Vulnerable Populations
NCT05315908
Community-engaged Approaches to Testing in Community and Healthcare Settings for Underserved Populations
NCT04870307
Evaluating the Impact of an Equity Focused Dashboard and Clinical Support
NCT05278806
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
RADx CHCs testing intervention strategy
Six Massachusetts community health center partnerships implementing both a common testing expansion implementation strategy plus tailored strategies designed for community partner needs.
RADx CHCs testing intervention strategy
The study team will support partner CHCs to implement workflows with some combination of dedicated testing staff, off-site testing, outreach/communications to priority populations, and linkage with local contact tracing systems. Implementation support will take the form of practice facilitation, rapid cycle testing (by supporting CHCs to review their internal data to assess the impact of workflow changes), and expert consultation from the research team on testing technology and testing location design.
Usual care control
Usual care control
CHCs implement testing strategies in accordance with their usual supports.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
RADx CHCs testing intervention strategy
The study team will support partner CHCs to implement workflows with some combination of dedicated testing staff, off-site testing, outreach/communications to priority populations, and linkage with local contact tracing systems. Implementation support will take the form of practice facilitation, rapid cycle testing (by supporting CHCs to review their internal data to assess the impact of workflow changes), and expert consultation from the research team on testing technology and testing location design.
Usual care control
CHCs implement testing strategies in accordance with their usual supports.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dana-Farber Cancer Institute
OTHER
Harvard School of Public Health (HSPH)
OTHER
Massachusetts League of Community Health Centers
OTHER
National Cancer Institute (NCI)
NIH
Massachusetts General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Elsie Taveras, MD
Executive Director, Kraft Center for Community Health and Division Chief, General Academic Pediatrics
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elsie Taveras, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Massachusetts General Hospital
Karen Emmons, PhD
Role: PRINCIPAL_INVESTIGATOR
Harvard School of Public Health (HSPH)
Susan Dargon-Hart, LICSW
Role: PRINCIPAL_INVESTIGATOR
Massachusetts League of Community Health Centers
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Massachusetts League of Community Health Centers
Boston, Massachusetts, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020P003743
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.